Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey

ConclusionQuestions around optimal use of adjuvant bisphosphonates in patients with EBC still exist. There is interest among physicians in performing trials of de-escalation of these agents. The results of this survey will assist in designing pragmatic clinical trials to address this question.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research